On Parklawn Drive in North Bethesda, three warehouses from the early 1960s now contain wet labs, offices, coworking rooms and a rooftop vegetable garden. The 103,000-square-foot Greencourt Innovation Center is polished enough to carry a LEED Gold certification, but its old bones still make the better introduction. Sunwater Capital, the investment firm headquartered there, also likes to work by conversion: an overlooked building becomes a laboratory; unruly provider records become healthcare infrastructure; a local pharmacy becomes the front door to a Medicare plan.
That is a more useful way to understand Sunwater than calling it a venture fund or a real-estate investor. It is both, and also neither in the tidy institutional sense. Founded in 2017 by Stephany Yu and Matthew Chervenak, Sunwater invests across real estate, property technology, healthcare and information. The public portfolio includes ground-up developments and existing buildings, venture-backed software companies, data publishers, care-management businesses and an asset manager listed in China.
Most funds narrow their identity by stage, asset class or industry. Sunwater's identity comes from two operators and the domains they know. Yu built a career in development and investment, leading the creation of more than 36 million square feet of residential, commercial and retail property in the United States and China. Chervenak founded GBI, a pharmaceutical and biotechnology intelligence company, after work in strategy consulting and neuroscience research. Put those résumés together and the portfolio's strange geometry begins to look deliberate.
One firm, several kinds of plumbing
Sunwater's holdings make more sense if “infrastructure” is allowed to include the invisible kind. Parkridge V is a 202,000-square-foot office building. NoMa CNTR transformed a former Greyhound terminal site in Washington into a mixed-use development with apartments, a hotel and retail. Greencourt Properties has managed or developed more than 30 million square feet in mainland China. Those are recognizable physical assets.
Then consider Veda Data, which used automation to clean and manage healthcare-provider information. A bad directory entry looks trivial until a patient cannot find a doctor, a health plan cannot maintain a network or a provider does not get paid correctly. Sunwater joined Veda's $5 million Series A in 2020. H1 acquired the company in May 2025, folding its provider-data capability into a larger healthcare information platform. The pipes were digital, but the problem was as concrete as a broken elevator.
The same operational reading applies elsewhere. Kaizen Health coordinates non-emergency medical transportation, addressing the stubborn gap between scheduling care and physically reaching it. Mindoula manages behavioral-health populations whose needs often cross clinical and social systems. Troy Medicare builds Medicare Advantage around independent pharmacies and local providers. When Troy announced a $10 million Series B in 2020, Sunwater participated beside lead investor AXA Venture Partners.
The product is judgment, plus time
Sunwater does not sell a consumer product. Its offer to founders and management teams is capital, transaction flexibility and operating experience. The firm says it has a stable capital base, a long investment horizon and room for creative structures. Those claims matter because different assets run on different clocks. A healthcare startup may learn by shipping weekly. A mixed-use tower learns in permitting hearings, financing markets and construction seasons. A property conversion can require years before the neighborhood catches up.
Public materials suggest that Sunwater can move among minority venture rounds, private-equity transactions, development partnerships and direct real-estate ownership. Trademark registrations cover venture financing, project financing, real-estate development, investment management, healthcare financial consulting and merger advice. This is a toolkit, not a single fund format. The exact economics remain private: Sunwater does not publish its assets under management, fees, individual check sizes, revenue or valuation.
That flexibility is Sunwater's clearest distinction from a conventional sector fund. A healthtech investor might understand payer sales but not the lab space a young biotech team needs. A property fund might understand the building but not the information business operating inside it. Sunwater's wager is that familiarity with both the asset and the workflow creates more places to help - and more ways to structure a return.
A portfolio that behaves like a systems map
The 17 entries on Sunwater's site divide neatly enough into three systems. Six are principally places or real-estate platforms. Four deliver or coordinate care. Seven organize information, from senior-care intelligence and product-development analytics to congressional data and scientific publishing. That grouping is editorial rather than the firm's own filter, but it reveals the balance: Sunwater holds almost as much information infrastructure as property.
Public portfolio / editorial grouping
The newer information bets make the point. Legis1 organizes congressional, legislative and lobbying data for people who need to navigate government. AllSci uses artificial intelligence to help researchers explore hypotheses, evidence, visualizations, publishing and peer review. Reframe Data Services supports product development and the collection, integration and analysis of data. These companies do not share an end market. They share a belief that better-structured knowledge changes what an organization can do.
Customers therefore arrive at several levels. Sunwater's immediate counterparties are founders, executives, property partners, tenants and co-investors. Portfolio customers include health plans, patients, local pharmacies, care providers, life-science companies, researchers, policymakers and property users. The firm is not building a single funnel. It is assembling positions around expensive coordination problems.
What an operator gets besides a check
For an entrepreneur, Sunwater is most useful when the hard part of the business sits outside the product itself. A care company may have working software but still need to understand payer incentives, provider relationships and the service operation surrounding each clinical encounter. A data company may need to decide whether it is selling records, analysis, workflow or a decision. A property project may have a viable site but need a patient financing structure and a clearer picture of its future occupants. These are translation problems. They reward an investor that can ask operating questions before reaching for a valuation model.
The firm also has an internal bench that looks more like a holding company than a two-partner venture shop. Its public team page lists legal leadership, a chief financial officer, controllers, accountants, human-resources staff and office operations alongside the founders. Managing Director and General Counsel Aric Lavinthal's remit includes legal matters, deal management, operations and estate planning. CFO Stephanie Gualino's background includes transaction structuring, due diligence, international tax and cross-border strategy. That infrastructure is relevant for investments that may span entities, jurisdictions and asset types.
The alternatives depend on the deal. A digital-health founder can approach a specialist such as HealthX Ventures or a larger healthcare investment platform. A developer can seek a regional real-estate private-equity partner. An owner who wants time rather than a fixed exit clock can look to a family office. Sunwater competes across all three conversations, but its broad mandate will not be the best fit for every company. A highly specialized software startup may prefer a fund with a dense network in one narrow market. A property sponsor may simply want the cheapest available capital.
Sunwater's case is strongest when those choices cannot be cleanly separated. Greencourt's lab suites, for example, are at once a leasing product, a piece of biotech infrastructure and a platform for a local company network. Troy Medicare is an insurance product whose differentiation depends on pharmacy relationships and care operations as much as technology. Veda's value was embedded in the accuracy of data moving through health-plan workflows. In each case, capital alone was necessary but not very descriptive. The relevant expertise sat in understanding how the parts touched.
The warehouse is the thesis
Greencourt Innovation Center is where the abstract language of value creation becomes pleasantly literal. Yu saw potential in North Bethesda's warehouse district during a real-estate downturn. The team preserved the industrial character, converted three buildings and created a campus for growth companies. Today, listings advertise wet labs as small as 500 square feet, shared equipment, coworking areas and flexible offices. Proximity to the National Institutes of Health and the Food and Drug Administration turns location into a practical advantage for life-science tenants.
It is also a compact demonstration of Sunwater's market position. The real estate matters. So do the businesses inside, the services they require and the networks around them. A standard venture firm can finance a biotech tenant; a standard landlord can lease it a room. A platform that understands both may spot needs at the seam - the correct lab configuration, the flexible term, the neighboring operator, the patient timeline.
There are risks to such breadth. Expertise can become anecdote, and a flexible mandate can make performance difficult for outsiders to compare. The public record offers no fund returns or asset totals, so Sunwater's strategy can be evaluated more easily through its holdings than through a standard benchmark. The three exits marked on its site - GBI, Science and Medicine Group and Veda Data - provide some evidence of a repeatable information-business thread. Real estate, by design, tells its story more slowly.
The useful lesson is not that every investor should cover four sectors. It is that categories are sometimes less durable than capabilities. Yu knows how physical assets acquire value. Chervenak knows how specialized information becomes a business. Sunwater applies those capabilities wherever the operating problem is legible, whether the object is a directory, a ride to a clinic or an old warehouse waiting for a second life.